Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility.
Anthony Martin MenaLaura NégrierAnthony TreizebréMarie GuilbertLucille BonnaireValentine DaniauGabie Leba BonkiPascal OdouStéphanie GenayBertrand DécaudinPublished in: Pharmaceutics (2023)
It is important to systematically compare the efficacy of strategies for preventing drug incompatibility. The use of diluted vancomycin solution gave the best results in the case of vancomycin-piperacillin/tazobactam incompatibility.